Investopedia: AstraZeneca Looks To Fish Oil To Round Out Its Cardio Portfolio

Investors waiting for M&A activity in the controversial purified pharma-grade fish oil market got some Tuesday morning, but probably n...

Investopedia: Another Negative Fish Oil Study Adds To Amarin's Marketing Challenges

Nothing has come easy for Amarin (Nasdaq: AMRN ). This manufacturer of the ultra-pure fish oil (EPA in particular) treatment Vascepa has ...